A detailed history of Main Management ETF Advisors, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Main Management ETF Advisors, LLC holds 45,008 shares of CDNA stock, worth $927,614. This represents 0.07% of its overall portfolio holdings.

Number of Shares
45,008
Holding current value
$927,614
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$14.41 - $33.99 $648,565 - $1.53 Million
45,008 New
45,008 $1.41 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.1B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Main Management ETF Advisors, LLC Portfolio

Follow Main Management ETF Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Management ETF Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Management ETF Advisors, LLC with notifications on news.